AZZOLINI, MICHELE
AZZOLINI, MICHELE
Istituto di Neuroscienze - IN -
Pterostilbene Improves Cognitive Performance in Aged Rats: An in Vivo Study
2019 La Spina, M.; Sansevero, G.; Biasutto, L.; Zoratti, M.; Peruzzo, R.; Berardi, N.; Sale, A.; Azzolini, M.
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo
2017 Leanza L.; Romio M.; Becker K.A.; Azzolini M.; Trentin L.; Manago A.; Venturini E.; Zaccagnino A.; Mattarei A.; Carraretto L.; Urbani A.; Kadow S.; Biasutto L.; Martini V.; Severin F.; Peruzzo R.; Trimarco V.; Egberts J.H.; Hauser C.; Visentin A.; Semenzato G.; Kalthoff H.; Zoratti M.; Gulbins E.; Paradisi C.; Szabo I.
New natural amino acid-bearing prodrugs boost pterostilbene's oral pharmacokinetic and distribution profile
2017 Azzolini, M; Mattarei, A; La Spina, M; Fanin, M; Chiodarelli, G; Romio, M; Zoratti, M; Paradisi, C; Biasutto, L
Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue
2017 Mattarei, A; Rossa, A; Bombardelli, V; Azzolini, M; La Spina, M; Paradisi, C; Zoratti, M; Biasutto, L
Resveratrol derivatives as a pharmacological tool
2017 Biasutto, L; Mattarei, A; Azzolini, M; La Spina, M; Sassi, N; Romio, M; Paradisi, C; Zoratti, M
Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells
2017 Venturini E.; Leanza L.; Azzolini M.; Kadow S.; Mattarei A.; Weller M.; Tabatabai G.; Edwards M.J.; Zoratti M.; Paradisi C.; Szabo I.; Gulbins E.; Becker K.A.
Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma
2017 Zaccagnino, A.; Managò, A.; Leanza, L.; Gontarewitz, A.; Linder, B.; Azzolini, M.;, Biasutto, L.; Zoratti, M.; Peruzzo, R.; Legler, K.; Trauzold, A.; Kalthoff, H.; Szabo, I.
The mitochondrial permeability transition pore in AD 2016: An update
2016 Biasutto, Lucia; Azzolini, Michele; Szabo, Ildiko; Zoratti, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pterostilbene Improves Cognitive Performance in Aged Rats: An in Vivo Study | 1-gen-2019 | La Spina, M.; Sansevero, G.; Biasutto, L.; Zoratti, M.; Peruzzo, R.; Berardi, N.; Sale, A.; Azzolini, M. | |
| Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo | 1-gen-2017 | Leanza L.; Romio M.; Becker K.A.; Azzolini M.; Trentin L.; Manago A.; Venturini E.; Zaccagnino A.; Mattarei A.; Carraretto L.; Urbani A.; Kadow S.; Biasutto L.; Martini V.; Severin F.; Peruzzo R.; Trimarco V.; Egberts J.H.; Hauser C.; Visentin A.; Semenzato G.; Kalthoff H.; Zoratti M.; Gulbins E.; Paradisi C.; Szabo I. | |
| New natural amino acid-bearing prodrugs boost pterostilbene's oral pharmacokinetic and distribution profile | 1-gen-2017 | Azzolini, M; Mattarei, A; La Spina, M; Fanin, M; Chiodarelli, G; Romio, M; Zoratti, M; Paradisi, C; Biasutto, L | |
| Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue | 1-gen-2017 | Mattarei, A; Rossa, A; Bombardelli, V; Azzolini, M; La Spina, M; Paradisi, C; Zoratti, M; Biasutto, L | |
| Resveratrol derivatives as a pharmacological tool | 1-gen-2017 | Biasutto, L; Mattarei, A; Azzolini, M; La Spina, M; Sassi, N; Romio, M; Paradisi, C; Zoratti, M | |
| Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells | 1-gen-2017 | Venturini E.; Leanza L.; Azzolini M.; Kadow S.; Mattarei A.; Weller M.; Tabatabai G.; Edwards M.J.; Zoratti M.; Paradisi C.; Szabo I.; Gulbins E.; Becker K.A. | |
| Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma | 1-gen-2017 | Zaccagnino, A.; Managò, A.; Leanza, L.; Gontarewitz, A.; Linder, B.; Azzolini, M.;, Biasutto, L.; Zoratti, M.; Peruzzo, R.; Legler, K.; Trauzold, A.; Kalthoff, H.; Szabo, I. | |
| The mitochondrial permeability transition pore in AD 2016: An update | 1-gen-2016 | Biasutto, Lucia; Azzolini, Michele; Szabo, Ildiko; Zoratti, Mario |